未登录

V

Václav Pflégr

charles university

H指数:6

被引数:124

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design, synthesis and antitubercular evaluation of 2,5-disubstituted 1,3,4-oxadiazoles bearing a 3,5-dinitrophenyl pharmacophore

2,5-二取代-1,3,4-噁二唑类化合物的设计、合成及抗结核活性评价，其中含有3,5-二硝基苯基药效团

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2026-08-040

OAAI

Activity Profiling of Nitro-Substituted Di(Hetero)Aryl 1,3,4- and 1,2,4-Oxadiazoles: Antimicrobial, Cholinesterase Inhibition and Antioxidant Potential

Archiv der Pharmazie

IF3.6

2026-01-200

OAAI

4-[(Aryloylhydrazineylidene)methyl]-N-phenylbenzamides as a new class of antimycobacterial agents: design, synthesis and biological evaluation

Bioorganic Chemistry

IF4.7

2026-01-170

OAAI

Enhancing the antimycobacterial efficacy of pyridine-4-carbohydrazide: linkage to additional antimicrobial agents via oxocarboxylic acids

RSC MEDICINAL CHEMISTRY

IF3.6

2025-01-010

OAAI

Novel pyrimidine-1,3,4-oxadiazole hybrids and their precursors as potential antimycobacterial agents

FUTURE MEDICINAL CHEMISTRY

IF3.4

2023-08-092

OA

Novel Inhibitors of Acetyl- and Butyrylcholinesterase Derived from Benzohydrazides: Synthesis, Evaluation and Docking Study

PHARMACEUTICALS

IF4.8

2023-01-242

OAAI

5-Aryl-1,3,4-oxadiazol-2-amines Decorated with Long Alkyl and Their Analogues: Synthesis, Acetyl- and Butyrylcholinesterase Inhibition and Docking Study

PHARMACEUTICALS

IF4.8

2022-03-255

OAAI

Design and Synthesis of Highly Active Antimycobacterial Mutual Esters of 2-(2-Isonicotinoylhydrazineylidene)propanoic Acid

PHARMACEUTICALS

IF4.8

2021-12-144

OAAI

Design and synthesis of 2-(2-isonicotinoylhydrazineylidene) propanamides as InhA inhibitors with high antitubercular activity

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2021-11-0120

PREAI

Iodinated 1,2-diacylhydrazines, benzohydrazide-hydrazones and their analogues as dual antimicrobial and cytotoxic agents

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2021-07-0118

PRE